癌転移における系統トランス分化の進化
Yu Xiao1,2, Wan Jin1,2, Fangjin Chen3
1Department of Biological Repositories, Human Genetic Resources Preservation Center of Hubei Province, Laboratory of Precision Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Research (Washington, D.C.)
|February 23, 2026
まとめ
がん細胞はトランス分化を通じてそのアイデンティティを変えることができ、これは転移に不可欠なプロセスです。MAPKシグナル伝達に関連するこのエピジェネティックな再プログラミングは、がんの拡散を防ぐための新しい治療標的を提供します。
科学分野:
- 癌生物学
- エピジェネティクス
- 細胞分化
背景:
- 癌における遺伝子変異はよく研究されていますが、転移を駆動する非遺伝的メカニズムはあまり理解されていません。
- 癌転移は一次腫瘍と共通の突然変異プロファイルを共有することが多く、拡散の代替ドライバーを示唆しています。
主な方法:
- 癌の表現型進化の単一細胞解像度再構築のためのバイオインフォマティクスツールの開発。
- 転移進行中の転写およびエピゲノム系統忠実性の分析。
- トランス分化と臨床データ(組織病理学的グレード、生存率)およびシグナル伝達経路との相関。
結論:
- エピジェネネティックな再プログラミングによって駆動される系統トランス分化は、癌転移の基本的なメカニズムです。
- 活性化されたMAPKシグナル伝達は、トランス分化と転移を促進します。
- MAPK阻害を介したトランス分化の逆転は、癌の拡散に対する潜在的な治療戦略となります。
関連する概念動画
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Forced Transdifferentiation
2.4K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
2.4K
Cancers Originate from Somatic Mutations in a Single Cell
15.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.0K
Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Cancer Stem Cells and Tumor Maintenance
6.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K


